MEDICATION
First Line
- RHO immunoglobulin in Rh-negative women:
- 50
μ
g for women with threatened or complete abortion at <12 wk
- 300
μ
g for women with threatened or complete abortion at ≥12 wk
- Patients need RhoGAM administration within 72 hr to prevent future isoimmunization
- Misoprostol 800 μg vaginally if medical management is chosen in consultation with OB/GYN
- Repeat dose required in 48 hr
Second Line
Usually given in consultation with OB/GYN:
- Oxytocin: 20 IU in 1,000 mL of NS at a rate of 20 mIU/min titrated to decrease bleeding; may repeat for a max. dose of 40 mIU/min
- Methylergonovine: 0.2 mg IM/PO QID for bleeding
FOLLOW-UP
DISPOSITION
Admission Criteria
- Suspected unstable ectopic pregnancy (see “Ectopic Pregnancy”)
- Hemodynamically unstable patients with hypovolemia or anemia
- DIC
- Septic abortions
- Suspected gestational trophoblastic disease
Discharge Criteria
- D&Cs can be done in the ED for incomplete and inevitable abortions, and patients may be discharged home if stable after 2–3 hr
- Some early inevitable miscarriages can be discharged to complete their miscarriages at home without a D&C
- Discharge with pain medications and close OB/GYN follow-up
- Patients with threatened abortions should be told to avoid strenuous activity
- Pelvic rest (i.e., “nothing in the vagina” during active bleeding; may increase risk of infection)
- Patients should be instructed to return to the ED for any increase in bleeding, dizziness, or temperature >100.4°F
- Patients and their partners should be counseled that early pregnancy loss is common and that it is not anyone’s fault
FOLLOW-UP RECOMMENDATIONS
Patients with positive pregnancy tests and vaginal bleeding with or without abdominal pain should be followed by OB/GYN.
PEARLS AND PITFALLS
- Recognize the possibility of ectopic pregnancy
- Patients with spontaneous abortion may have clinically significant blood loss
ADDITIONAL READING
- Huancahuari N. Emergencies in early pregnancy.
Emerg Med Clin North Am
. 2012;30:837–847.
- Martonffy AI, Rindfleisch K, Lozeau AM, et al. First trimester complications.
Prim Care
. 2012;39:71–82.
- Marx JA, Hockberger RS, Walls RM, et al.
Rosen’s Emergency Medicine: Concepts and Clinical Practice
. 7th ed. St. Louis, MO: Mosby; 2009.
- Prine LW, MacNaughton H. Office management of early pregnancy loss.
Am Fam Physician
. 2011;84:75–82.
See Also (Topic, Algorithm, Electronic Media Element)
- Ectopic Pregnancy
- Vaginal Bleeding
CODES
ICD9
- 634.90 Spontaneous abortion, without mention of complication, unspecified
- 634.91 Spontaneous abortion, without mention of complication, incomplete
- 634.92 Spontaneous abortion, without mention of complication, complete
ICD10
- O02.1 Missed abortion
- O03.4 Incomplete spontaneous abortion without complication
- O03.9 Complete or unspecified spontaneous abortion without complication
ABSCESS, SKIN/SOFT TISSUE
Neal P. O’Connor
BASICS
DESCRIPTION
- A localized collection of pus surrounded and walled off by inflamed tissue. Abscesses can occur on any part of the body
- Furuncle:
- Arises from infected hair follicle
- Most common on back, axilla, and lower extremities
- Carbuncle:
- Larger and more extensive than furuncle
- Dog/cat bite:
- Breast:
- Puerperal:
- Usually during lactation
- Located in peripheral wedge
- Usually staphylococci
- Duct ectasia:
- Caused by ecstatic ducts
- Periareolar location
- Usually polymicrobial
- Hidradenitis suppurativa:
- Chronic abscess of apocrine sweat glands
- Groin and scalp
- Staphylococcus aureus
and
staphylococcus viridans
are common
- Escherichia coli
and
Proteus
may be present in chronic disease
- Pilonidal abscess:
- Epithelial disruption of gluteal fold over coccyx
- Staphylococcal species are most common
- May be polymicrobial
- Bartholin abscess:
- Obstruction of Bartholin duct
- Perirectal abscess:
- Originates in anal crypts and extends through ischiorectal space
- Inflammatory bowel disease and diabetes are predisposing factors
- Bacteroides fragilis
and
E. coli
are most common
- Requires operative drainage
- Muscle (pyomyositis):
- Typically in the tropics
- S. aureus
is most common
- IV drug abuse:
- Staphylococcal species are most common
- MRSA is common
- May be sterile
- Paronychia:
- Infection around nail fold
- Usually
S. aureus
- Felon:
- Closed space abscess in distal pulp of finger
- Usually
S. aureus
ETIOLOGY
- Abscess formation typically occurs due to a break in the skin, obstruction of sebaceous or sweats glands, or inflammation of hair follicles. The collection may be classified as bacterial or sterile:
- Bacterial: Most abscesses are bacterial with the microbiology reflective of the microflora of the involved body part:
- S. aureus
is the most common causative organism
- Community-acquired MRSA (CA-MRSA) common
- Sterile: More associated with IV drug abuse and injection of chemical irritants
- Risk factors for abscess formation:
- Immunosuppression
- Soft tissue trauma
- Mammalian/human bites
- Tissue ischemia
- IV drug use
- Chron's disease (perirectal)
DIAGNOSIS
SIGNS AND SYMPTOMS
- Local:
- Erythema
- Tenderness
- Heat
- Swelling
- Fluctuance
- May have surrounding cellulitis
- Regional lymphadenopathy and lymphangitis may occur
- Systemic:
- Often absent
- Patients with extensive soft tissue involvement, necrotizing fasciitis, or underlying bacteremia may present with signs of sepsis including:
- Fever
- Rigors
- Hypotension
- Altered mentation
History
- Previous episodes: Raise concern for CA-MRSA
- Immunosuppression
- Medications:
- Chronic steroids, chemotherapy
- IVDU
- History of mammalian bite
Physical-Exam
- Location and extent of infection
- Presence of:
- Associated cellulitis
- Subcutaneous air
- Deep structure involvement
- Involvement of specialty area:
ESSENTIAL WORKUP
- History and physical exam
- Gram stain unnecessary for simple abscesses in healthy patients
- Wound cultures:
- Not indicated in simple abscesses
- May help guide therapy if systemic treatment is planned
- May be useful in confirming CA-MRSA in patients with recurrent abscesses
- May guide specific therapy in a compromised host, abscesses of the central face or hand, and treatment failures